Targeting cancer with bispecific antibodies
- PMID: 33649167
- DOI: 10.1126/science.abg5568
Targeting cancer with bispecific antibodies
Comment on
-
Targeting a neoantigen derived from a common TP53 mutation.Science. 2021 Mar 5;371(6533):eabc8697. doi: 10.1126/science.abc8697. Epub 2021 Mar 1. Science. 2021. PMID: 33649166 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
